These data provide reassurance to prescribers that doubling the dose of Seretide™ for a short period of time is unlikely to result in any clinically relevant β 2-agonist- or inhaled ...

30 in The BMJ. William B. Feldman, M.D., M.P.H., from Brigham and Women’s Hospital in Boston, and colleagues compared the effectiveness and safety of budesonide-glycopyrrolate-formoterol, a ...